H. L. de Matos Guedes

This study shows that Leishmania amazonensis infection increases PD-L1 on dendritic cells via mTOR, leading to impaired Th1 responses and promoting lesion resolution.

This study evaluates a vaccine strategy using Alum and Poly(I:C) adjuvants with SARS-CoV-2 spike protein, showing enhanced antibody and T-cell responses and reduced lung inflammation.

This study investigates the therapeutic effects of anti-PD-1 and anti-PD-L1 antibodies in Leishmania amazonensis-infected mice, showing increased IFN-γ production and reduced parasite load.